IN VITRO CYTOTOXIC ACTIVITY OF RODENT TUBER MUTANT PLANT (TYPHONIUM FLAGELLIFORME LODD.) AGAINST TO MCF-7 BREAST CANCER CELL LINE

Journal Title: Asian Journal of Pharamceutical and Clinical Research - Year 2019, Vol 12, Issue 3

Abstract

Objective: The objective of this study was to determine the new bioactive compounds through gas chromatography–mass spectrometry analysis and the cytotoxic activity of two rodent tuber mutant plants against breast cancer cells (MCF-7). Methods: The bioactive compounds in rodent tuber mutant plants were successfully increased by somaclonal variation using gamma rays irradiation technique. Further, the cytotoxicity activity of rodent tuber mutant plants was tested on breast cancer cell line (MCF-7) performed by 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyltetrazolium bromide assay method. Results: This results study confirmed that the presence of phytochemical composition in the tuber of rodent tuber mutant plants KB 6–1–3–4 and KB 6–9–5 was found six bioactive compounds from fatty acid groups which have the potential as an anticancer compound, such as octadecanoic acid, hexadecanoic acid, hexadecanoic acid methyl ester, 9-octadecanoic acid, linolelaidic acid methyl ester, and butanoic acid. The results showed that extracts from rodent tuber mutant plants had a cytotoxicity effect on MCF-7 cancer cells with half maximal inhibitory concentration (IC50) values that were lower than the control (mother plant). In vitro tests of KB 6–1–3–4 and KB 6–9–5 against MCF-7 cancer cell lines have IC50 values of 12.482 μg/mL and 7.043 μg/mL, respectively, while it had a lower cytotoxicity effect with the IC50 value of control plant was 19.113 μg/mL. The mutant plants of KB 6-9-5 have 3 times more effective than control. Conclusion: The results of this study clearly indicated that rodent tuber mutant plants have shown promising as an anticancer drug on breast cancer.

Authors and Affiliations

NESTI FRONIKA SIANIPAR, KHOIRUNNISA ASSIDQI, RAGAPADMI PURNAMANINGSIH, TATI HERLINA

Keywords

Related Articles

NANOSTRUCTURE LIPID CARRIERS: A PROMISING TOOL FOR THE DRUG DELIVERY IN THE TREATMENT OF SKIN CANCERNANOSTRUCTURE LIPID CARRIERS: A PROMISING TOOL FOR THE DRUG DELIVERY IN THE TREATMENT OF SKIN CANCER

Skin cancer is the most common type of cancer having a very high rate of incidence, exceeding the sum of all other types of cancers. Current topical treatments for non-melanoma skin cancer and their precursor lesions, su...

IN VITRO CYTOTOXIC ANTICANCER POTENTIAL OF BIOACTIVE FRACTION ISOLATED FROM INDONESIAN TIDAL SPONGE CALTHROPELLA SP.

Objective: This study was taken to examine the cytotoxicity of the bioactive fraction isolated from marine sponge Calthropella sp. as a preliminary anticancer assay and identify its bioactive compounds.Methods: The cytot...

ARTEMISININ CONTENT ON ARTEMISIA ANNUA L. TREATED BY GLORIOSA SUPERBA SEEDS’ WATER EXTRACT

Objective: The aim of this study was to determine the artemisinin content on Artemisia annua L. treated by water extract of Gloriosa superba seeds.Methods: G. superba seeds obtained naturally on Krakal Beach, Gunung Kidu...

DIAGNOSTIC METHODS FOR NON-ALCOHOLIC FATTY LIVER DISEASES ALTERNATIVE TO LIVER BIOPSY: A REVIEW

Non-alcoholic fatty liver diseases (NAFLD) are the most occurring chronic liver diseases caused by hepatic manifestation of metabolic syndromeslike insulin resistance in Type-2 diabetes, obesity and hyperlipidemic condit...

AWARENESS, KNOWLEDGE AND ATTITUDE TOWARDS PHARMACOVIGILANCE AMONG MEDICAL GRADUATES IN A TERTIARY CARE TEACHING HOSPITAL IN SOUTH INDIA.

Objectives: As an ever growing scale people are using newer and more effective drugs for various medical conditions. Adverse drug reactions (ADRs) are preventable if the health-care professional pays close attention to t...

Download PDF file
  • EP ID EP603850
  • DOI -
  • Views 94
  • Downloads 0

How To Cite

NESTI FRONIKA SIANIPAR, KHOIRUNNISA ASSIDQI, RAGAPADMI PURNAMANINGSIH, TATI HERLINA (2019). IN VITRO CYTOTOXIC ACTIVITY OF RODENT TUBER MUTANT PLANT (TYPHONIUM FLAGELLIFORME LODD.) AGAINST TO MCF-7 BREAST CANCER CELL LINE. Asian Journal of Pharamceutical and Clinical Research, 12(3), 185-189. https://europub.co.uk/articles/-A-603850